These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15905580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adenosine produced from adenine nucleotides through an interaction between apoptotic cells and engulfing macrophages contributes to the appearance of transglutaminase 2 in dying thymocytes.
    Sándor K, Pallai A, Duró E, Legendre P, Couillin I, Sághy T, Szondy Z.
    Amino Acids; 2017 Mar; 49(3):671-681. PubMed ID: 27236567
    [Abstract] [Full Text] [Related]

  • 6. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
    Boisvert WA, Rose DM, Boullier A, Quehenberger O, Sydlaske A, Johnson KA, Curtiss LK, Terkeltaub R.
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
    [Abstract] [Full Text] [Related]

  • 7. Transglutaminase type II is involved in the pathogenesis of endotoxic shock.
    Falasca L, Farrace MG, Rinaldi A, Tuosto L, Melino G, Piacentini M.
    J Immunol; 2008 Feb 15; 180(4):2616-24. PubMed ID: 18250473
    [Abstract] [Full Text] [Related]

  • 8. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells.
    Tóth B, Garabuczi E, Sarang Z, Vereb G, Vámosi G, Aeschlimann D, Blaskó B, Bécsi B, Erdõdi F, Lacy-Hulbert A, Zhang A, Falasca L, Birge RB, Balajthy Z, Melino G, Fésüs L, Szondy Z.
    J Immunol; 2009 Feb 15; 182(4):2084-92. PubMed ID: 19201861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice.
    Grainger DJ, Reckless J, McKilligin E.
    J Immunol; 2004 Nov 15; 173(10):6366-75. PubMed ID: 15528376
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.
    Nadella V, Wang Z, Johnson TS, Griffin M, Devitt A.
    Biochim Biophys Acta; 2015 Jan 15; 1853(1):201-12. PubMed ID: 25449226
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
    Johnson KA, van Etten D, Nanda N, Graham RM, Terkeltaub RA.
    J Biol Chem; 2003 May 23; 278(21):18824-32. PubMed ID: 12606540
    [Abstract] [Full Text] [Related]

  • 15. Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions.
    Diaz-Hidalgo L, Altuntas S, Rossin F, D'Eletto M, Marsella C, Farrace MG, Falasca L, Antonioli M, Fimia GM, Piacentini M.
    Biochim Biophys Acta; 2016 Aug 23; 1863(8):2084-92. PubMed ID: 27169926
    [Abstract] [Full Text] [Related]

  • 16. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
    Norsworthy PJ, Fossati-Jimack L, Cortes-Hernandez J, Taylor PR, Bygrave AE, Thompson RD, Nourshargh S, Walport MJ, Botto M.
    J Immunol; 2004 Mar 15; 172(6):3406-14. PubMed ID: 15004139
    [Abstract] [Full Text] [Related]

  • 17. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
    Van Herck JL, Schrijvers DM, De Meyer GR, Martinet W, Van Hove CE, Bult H, Vrints CJ, Herman AG.
    J Vasc Res; 2010 Mar 15; 47(3):231-40. PubMed ID: 19893320
    [Abstract] [Full Text] [Related]

  • 18. ATP-binding cassette transporter 1 and transglutaminase 2 act on the same genetic pathway in the apoptotic cell clearance.
    Iadevaia V, Rinaldi A, Falasca L, Pucillo LP, Alonzi T, Chimini G, Piacentini M.
    Cell Death Differ; 2006 Nov 15; 13(11):1998-2001. PubMed ID: 16691213
    [No Abstract] [Full Text] [Related]

  • 19. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition.
    Cvetanovic M, Ucker DS.
    J Immunol; 2004 Jan 15; 172(2):880-9. PubMed ID: 14707059
    [Abstract] [Full Text] [Related]

  • 20. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
    Colak G, Johnson GV.
    Neurobiol Dis; 2012 Mar 15; 45(3):1042-50. PubMed ID: 22198379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.